22nd September 2020 Editorial by: rapidmicrobiology staff writer
Spanish Firm Announce Ready-to-Use Flu & COVID-19 qPCR Kits
Genetic PCR Solutions™ (GPS™) has developed a qPCR kit for the rapid detection of Influenza A and Influenza B viruses.
As Influenza and COVID-19 have similar symptoms, the GPS team anticipated a need for a test to differentiate between these respiratory viruses and began developing and designing a test a few months ago.
The kit is broadly specific, with the ability to detect Influenza A and B viruses and can be used simultaneously with its qPCR kit for COVID-19.
Both assays (Influenza A and B and COVID-19) use the same thermal protocol, which allows the same sample to be used in the same PCR run.
This new kit, which is now available in RUO format, has been internally validated in GPS™ laboratories using full genomes from 3 strains of Influenza, following strict recommendations of international standards and is being tested in hospitals with real and reference samples.
It will be submitted soon to reference laboratory Instituto de Salud Carlos III (ISCIII) for diagnostic validation. It will also participate in an international inter-laboratory exercise, and be registered in the Agencia Española de Medicamentos y Productos Sanitarios to obtain the CE-IVD mark.
With this new influenza diagnostic kit, GPS shows once again its innovative nature and its agility in developing products for the control of epidemic outbreaks that threaten global health.
Date Published: 22nd September 2020
Source article link: View